Amgen (AMGN) PT Lowered to $292 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel deepen AI capex concerns
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $470.14 +2.04%
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 44 | New: 9
Rating Summary:
18 Buy, 20 Hold, 5 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 44 | New: 9
Join SI Premium – FREE
Oppenheimer analyst Jay Olson lowered the price target on Amgen (NASDAQ: AMGN) to $292.00 (from $294.00) while maintaining a Outperform rating.
You May Also Be Interested In
- FDA: Amgen Vectibix promotional video found false or misleading
- Amgen (AMGN) call put ratio 5.4 calls to 1 put with a focus on November 505 calls into quarter results
- Stryker (SYK) PT Lowered to $309 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
